The diagnostic arsenal has since expanded, with ISL LIM homeobox 1 (ISL1), INSM transcriptional repressor 1 (INSM1), and secretagogin (SECG) to name a few novel markers exhibiting high sensitivity and specificity for neuroendocrine neoplasms (NENs). This evidence concerns the gene INSM1 and neuroendocrine neoplasm.